Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. (Record no. 21901411)

MARC details
000 -LEADER
fixed length control field 01504 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516100822.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201212s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1462-0332
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/rheumatology/kes097
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Galeotti, Caroline
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20121207
245 00 - TITLE STATEMENT
Title Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Rheumatology (Oxford, England)
Date of publication, distribution, etc. Oct 2012
300 ## - PHYSICAL DESCRIPTION
Extent 1855-9 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child, Preschool
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunologic Factors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin 1 Receptor Antagonist Protein
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-1beta
General subdivision antagonists & inhibitors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mevalonate Kinase Deficiency
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Meinzer, Ulrich
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Quartier, Pierre
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rossi-Semerano, Linda
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bader-Meunier, Brigitte
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pillet, Pascal
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Koné-Paut, Isabelle
773 0# - HOST ITEM ENTRY
Title Rheumatology (Oxford, England)
Related parts vol. 51
-- no. 10
-- p. 1855-9
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/rheumatology/kes097">https://doi.org/10.1093/rheumatology/kes097</a>
Public note Available from publisher's website

No items available.